Alfonso García
Research Subjects
Research Interests
Alfonso García has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alexza Pezoa
Laboratorios de Sanidad Animal, Departamento Red SAG de Laboratorios, Servicio Agrícola Ganadero, Santiago 7500007, Chile
1 shared publication - Antonia Maturana
Unidad Medicina y Cirugía Equina, Escuela Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Camino Lo Pinto Km 2,5 Colina, Santiago 9340000, Chile
1 shared publication - Carolyn Ahumada
Laboratorios de Sanidad Animal, Departamento Red SAG de Laboratorios, Servicio Agrícola Ganadero, Santiago 7500007, Chile
1 shared publication - Felipe Lara
Unidad Medicina y Cirugía Equina, Escuela Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Camino Lo Pinto Km 2,5 Colina, Santiago 9340000, Chile
1 shared publication - Lutz Steffen Goehring
University of Kentucky Maxwell H Gluck Equine Research Center
1 shared publication - Macarena Suazo
Unidad Medicina y Cirugía Equina, Escuela Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Camino Lo Pinto Km 2,5 Colina, Santiago 9340000, Chile
1 shared publication
Latest Publications
- Open Access
First Equine Herpes Myeloencephalopathy (EHM) Outbreak in Chile
Equine herpes myeloencephalopathy (EHM) is a neurological disease in horses caused by Equine herpesvirus type 1 (EHV-1). It is a serious condition, often resulting in severe neurological deficits, and can be fatal. In this report, we discuss the first outbreak of EHM in Chile (clinical signs, epidemiology, diagnosis, and control measures). A total of 567 polo horses were kept at the facility: 58.4% mares, 41.6% geldings, and stallions. Mean age was 9.7 ± 0.132 years. Thirteen horses showed clinical signs of EHV-1, eight had fevers (1.4%), and eleven developed EHM (1.9%). Only six of the eleven EHM cases had high fevers (>39.5 °C). Mortality was 0.35% (index case and one additional case) and morbidity reached 3.35% (19/567). PCR testing was performed on 214 horses (37.7%); 13 tested positive (6.1%) and 201 negative (93.9%). Of PCR-positive horses, 53.8% showed clinical signs. Notably, 2.9% of PCR-negative horses also presented signs compatible with EHV-1. CT values among positive cases ranged from 30 to 39. This first EHM outbreak in Chile showed low morbidity and mortality. Rapid implementation of strict quarantine and biosecurity effectively limited spread. Further data on viral prevalence and types are needed to improve preparedness.
Open AccessFirst Equine Herpes Myeloencephalopathy (EHM) Outbreak in Chile
Equine herpes myeloencephalopathy (EHM) is a neurological disease in horses caused by Equine herpesvirus type 1 (EHV-1). It is a serious condition, often resulting in severe neurological deficits, and can be fatal. In this report, we discuss the first outbreak of EHM in Chile (clinical signs, epidemiology, diagnosis, and control measures). A total of 567 polo horses were kept at the facility: 58.4% mares, 41.6% geldings, and stallions. Mean age was 9.7 ± 0.132 years. Thirteen horses showed clinical signs of EHV-1, eight had fevers (1.4%), and eleven developed EHM (1.9%). Only six of the eleven EHM cases had high fevers (>39.5 °C). Mortality was 0.35% (index case and one additional case) and morbidity reached 3.35% (19/567). PCR testing was performed on 214 horses (37.7%); 13 tested positive (6.1%) and 201 negative (93.9%). Of PCR-positive horses, 53.8% showed clinical signs. Notably, 2.9% of PCR-negative horses also presented signs compatible with EHV-1. CT values among positive cases ranged from 30 to 39. This first EHM outbreak in Chile showed low morbidity and mortality. Rapid implementation of strict quarantine and biosecurity effectively limited spread. Further data on viral prevalence and types are needed to improve preparedness.